Literature DB >> 7796893

Prohibitin antiproliferative activity and lack of heterozygosity in immortalized cell lines.

E R Jupe1, X T Liu, J L Kiehlbauch, J K McClung, R T Dell'Orco.   

Abstract

Experiments were performed to determine whether prohibitin, an evolutionarily conserved gene with antiproliferative activity, has a role in cellular immortalization. A cell proliferation assay was used to examine one human cell line from each of four established immortal complementation groups, termed A, B, C, and D, and a normal human diploid fibroblast line. Only normal and Group B cells were inhibited from traversing the cell cycle after introduction of wild-type prohibitin transcript. All of the immortalized cells expressed elevated levels of prohibitin mRNA and protein. Prohibitin gene structural characterization using Southern and single-strand conformation polymorphism (SSCP) analyses distinguished two alleles. One is cleaved at a polymorphic intronic EcoRI site, exhibits an exon 6-associated SSCP, and is homozygous only in Group B cells. The other is not cleaved at the EcoRI site, has a different exon 6 SSCP pattern, and is homozygous in Groups A, C, and D. In contrast, normal cells are heterozygous for the alleles. These results suggest that prohibitin may play a role as a tumor suppressor in the immortalization of Group B cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796893     DOI: 10.1006/excr.1995.1194

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  13 in total

1.  Prohibitin facilitates cellular senescence by recruiting specific corepressors to inhibit E2F target genes.

Authors:  Shipra Rastogi; Bharat Joshi; Piyali Dasgupta; Mark Morris; Kenneth Wright; Srikumar Chellappan
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

2.  Nanoparticle-based therapeutic delivery of prohibitin to the colonic epithelial cells ameliorates acute murine colitis.

Authors:  Arianne L Theiss; Hamed Laroui; Tracy S Obertone; Indrajit Chowdhury; Winston E Thompson; Didier Merlin; Shanthi V Sitaraman
Journal:  Inflamm Bowel Dis       Date:  2010-09-24       Impact factor: 5.325

3.  Prohibitin, a putative negative control element present in Pneumocystis carinii.

Authors:  S Narasimhan; M Armstrong; J K McClung; F F Richards; E K Spicer
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

4.  Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells.

Authors:  Nish Patel; Sabarni K Chatterjee; Vladimir Vrbanac; Ivy Chung; Chunyao Jenny Mu; Rachelle R Olsen; Carol Waghorne; Bruce R Zetter
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-25       Impact factor: 11.205

5.  Prohibitin inhibits tumor necrosis factor alpha-induced nuclear factor-kappa B nuclear translocation via the novel mechanism of decreasing importin alpha3 expression.

Authors:  Arianne L Theiss; Aaron K Jenkins; Ngozi I Okoro; Jan-Michael A Klapproth; Didier Merlin; Shanthi V Sitaraman
Journal:  Mol Biol Cell       Date:  2009-08-26       Impact factor: 4.138

6.  Prohibitin: a potential biomarker for tissue-based detection of gastric cancer.

Authors:  Xiangdong Kang; Long Zhang; Jian Sun; Zhenhua Ni; Yanchun Ma; Xiaobo Chen; Xia Sheng; Teng Chen
Journal:  J Gastroenterol       Date:  2008-08-17       Impact factor: 7.527

7.  Prohibitin physically interacts with MCM proteins and inhibits mammalian DNA replication.

Authors:  Wasia Rizwani; Mark Alexandrow; Srikumar Chellappan
Journal:  Cell Cycle       Date:  2009-05-27       Impact factor: 4.534

Review 8.  Prohibitin( PHB) roles in granulosa cell physiology.

Authors:  Indrajit Chowdhury; Kelwyn Thomas; Winston E Thompson
Journal:  Cell Tissue Res       Date:  2016-01       Impact factor: 5.249

9.  Comparative proteome analysis of Tumor necrosis factor α-stimulated human Vascular Smooth Muscle Cells in response to melittin.

Authors:  Hyun-Ji Cho; Jeong-Han Kang; Kwan-Kyu Park; Jung-Yoon Choe; Yoon-Yub Park; Yong-Suk Moon; Il-Kyung Chung; Hyeun-Wook Chang; Cheorl-Ho Kim; Yung Hyun Choi; Wun-Jae Kim; Sung-Kwon Moon; Young-Chae Chang
Journal:  Proteome Sci       Date:  2013-05-07       Impact factor: 2.480

10.  Comparison of Helicobacter bilis-Associated Protein Expression in Huh7 Cells Harbouring HCV Replicon and in Replicon-Cured Cells.

Authors:  Arinze S Okoli; Mark J Raftery; George L Mendz
Journal:  Int J Hepatol       Date:  2012-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.